Molecular identification of mutations conferring resistance to rifampin, isoniazid and pyrazinamide among Mycobacterium tuberculosis isolates from Iran

References

• Delogu G, Sali M, Fadda G. The biology of Mycobacterium tuberculosis infection. Mediterr J Hematol Infect Dis. 2013;5:e2013070.
   PubMedGoogle Scholar
• WHO. Global health observatory data repository 2018. Geneva: WHO; 2018.
   Google Scholar
• Espinal MA, Laszlo A, Simonsen L, Boulahbal F, Kim SJ, Reniero A, et al. Global trends in resistance to antituberculosis drugs. World Health Organization-International Union against Tuberculosis and Lung Disease Working Group on Anti-Tuberculosis Drug Resistance Surveillance. N Engl J Med. 2001;344:1294–1303.
   PubMed Web of Science ®Google Scholar
• Ministry of Health and Medical Education, Iran. Iranian center for disease control and prevention, division of TB and leprosy elimination, Iran: Ministry of Health and Medical Education; 2011. Available from: http://tb-lep.behdasht.gov.ir/Strong_TB_in_Iran.aspx. [accessed date 2016].
   Google Scholar
• WHO. Global Tuberculosis Report 2017. Geneva: WHO; 2017.
   Google Scholar
• Nasiri MJ, Dabiri H, Darban-Sarokhalil D, Rezadehbashi M, Zamani S. Prevalence of drug-resistant tuberculosis in Iran: systematic review and meta-analysis. Am J Infect Control. 2014;42:1212–1218.
   PubMed Web of Science ®Google Scholar
• Tavakoli A. Incidence and prevalence of tuberculosis in Iran and neighboring Countries. Zahedan J Res Med Sci. 2017;19:e9238.
   Google Scholar
• Nguyen L. Antibiotic resistance mechanisms in M. tuberculosis: an update. Arch Toxicol. 2016;90:1585–1604.
   PubMed Web of Science ®Google Scholar
• Leao SC, George Mejia, Jaime A. Robledo, Françoise Portaels, Anandi Martin, Palomino JC, et al. Practical handbook for the phenotypic and genotypic identification of mycobacteria. Brugges, Belgium: Vanden Broele; 2004.
   Google Scholar
• Canetti G, Froman S, Grosset J, Hauduroy P, Langerova M, Mahler HT, et al. Mycobacteria: laboratory methods for testing drug sensitivity and resistance. Bull World Health Org. 1963;29:565–578.
   PubMed Web of Science ®Google Scholar
• Carlos J, Palomino JC, Martin A. Drug resistance mechanisms in mycobacterium tuberculosis. Antibiotics (Basel.). 2014;3:317–340.
   PubMedGoogle Scholar
• Ahmed MM, Velayati AA, Mohammed SH. Epidemiology of multidrug-resistant, extensively drug resistant, and totally drug resistant tuberculosis in Middle East countries. Int J Mycobacteriol. 2016;5:249–256.
   PubMed Web of Science ®Google Scholar
• WHO. Global Tuberculosis Report 2015. Geneva: WHO; 2015.
   Google Scholar
• Tabarsi P, Chitsaz E, Baghaei P, Shamaei M, Farnia P, Marjani M, et al. Impact of extensively drug-resistant tuberculosis on treatment outcome of multidrug-resistant tuberculosis patients with standardized regimen: report from Iran. Microb Drug Resist. 2010;16:81–86.
   PubMed Web of Science ®Google Scholar
• Masjedi MR, Farnia P, Sorooch S, Pooramiri M, Mansoori SD, Zia Zarif A, et al. Extensively drug-resistant tuberculosis: 2 years of surveillance in Iran. Clin Infect Dis. 2006;43:841–847.
   PubMed Web of Science ®Google Scholar
• Masjedi MR, Tabarsi P, Baghaei P, Baghaei P, Jalali S, Farnia P, et al. Extensively drug-resistant tuberculosis treatment outcome in Iran: a case series of seven patients. Int J Infect Dis. 2010; 14:399–402.
   Web of Science ®Google Scholar
• Khademi F, Antimicrobial Resistance Research Center, Department of Medical Bacteriology and Virology, Qaem University Hospital, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran, Yousefi A, Derakhshan M, Vaez H, Sadeghi R. Middle East Mycobacterium tuberculosis antibiotic resistance: A systematic review and meta-analysis. IEM. 2017;3:25–35.
   Google Scholar
• Lin YH, Tai CH, Li CR, Lin CF, Shi ZY. Resistance profiles and rpoB gene mutations of Mycobacterium tuberculosis isolates in Taiwan. J Microbiol Immunol Infect. 2013;46:266–270.
   PubMedGoogle Scholar
• Doustdar F, Khosravi AD, Farnia P, Bahrmand AR, Masjedi MR, Velayati AA. Mutations in rpoB gene and genotypes of rifampin resistant Mycobacterium tuberculosis isolates in Iran. Tanaffos. 2008;7:11–17.
   Google Scholar
• Khosravi AD, Goodarzi H, Alavi SM. Detection of genomic mutations in katG, inhA and rpoB genes of Mycobacterium tuberculosis isolates using polymerase chain reaction and multiplex allele-specific polymerase chain reaction. Braz J Infect Dis. 2012;16:57–62.
   PubMed Web of Science ®Google Scholar
• Yao C, Zhu T, Li Y, Zhang L, Zhang B, Huang J, et al. Detection of rpoB, katG and inhA gene mutations in Mycobacterium tuberculosis clinical isolates from Chongqing as determined by microarray. Clin Microbiol Infect. 2010;16:1639–1643.
   PubMed Web of Science ®Google Scholar
• Kozhamkulov U, Akhmetova A, Rakhimova S, Belova E, Alenova A, Bismilda V, et al. Molecular characterization of rifampicin- and isoniazid-resistant Mycobacterium tuberculosis strains isolated in Kazakhstan . Jpn J Infect Dis. 2011;64:253–255.
   PubMed Web of Science ®Google Scholar
• Paluch-Oles J, Kozioł-Montewka M, Magrys A. Mutations in the rpoB gene of rifampin-resistant Mycobacterium tuberculosis isolates from eastern Poland. New Microbiol. 2009;32:147–152.
   PubMed Web of Science ®Google Scholar
• Avkan Oguz V, Eroglu C, Guneri S, Yapar N, Oztop A, Sanic A, et al. rpoB gene mutations in rifampin-resistant Mycobacterium tuberculosis strains isolated in the Aegean region of Turkey. J Chemother. 2004;16:442–445.
   PubMed Web of Science ®Google Scholar
• Qian L, Abe C, Lin TP, Yu MC, Cho SN, Wang S, et al. rpoB Genotypes of Mycobacterium tuberculosis Beijing Family Isolates from East Asian Countries. J Clin Microbiol. 2002;40:1091–1094.
   PubMed Web of Science ®Google Scholar
• Hazbón MH, Brimacombe M, Bobadilla del Valle M, Cavatore M, Guerrero MI, Varma-Basil M, et al. Population Genetics study of isoniazid resistance mutations and evolution of multidrug-resistant Mycobacterium tuberculosis. Antimicrob Agents Chemother. 2006;50:2640–2649.
   PubMed Web of Science ®Google Scholar
• Kardan-Yamchi J, Haeili M, Gizaw Feyisa S, Kazemian H, Hashemi Shahraki A, Zahednamazi, et al. Evaluation of efflux pump gene expression among drug susceptible and drug resistant strains of Mycobacterium tuberculosis from Iran. Infect Genet Evol. 2015;36:23–26.
   PubMed Web of Science ®Google Scholar
• Kardan-Yamchi J, Kazemian H, Haeili M, Harati AA, Amini S, Feizabadi MM. Expression analysis of 10 efflux pump genes in multidrug-resistant and extensively drug-resistant Mycobacterium tuberculosis clinical isolates. J Global Antimicrob Res. 2019;17:201–208.
   PubMed Web of Science ®Google Scholar
• Doustdar F, Khosravi AD, Farnia P, Masjedi MR, Velayati AA. Molecular analysis of isoniazid resistance in different genotypes of Mycobacterium tuberculosis isolates from Iran. Microb Drug Resist. 2008;14:273–279.
   PubMed Web of Science ®Google Scholar
• Sirous M, Khosravi A, Tabandeh MR, Salmanzadeh S, Ahmadkhosravi N, Amini A. Molecular detection of rifampin, isoniazid, and ofloxacin resistance in Iranian isolates of Mycobacterium tuberculosis by high-resolution melting analysis. IDR.. 2018;11:1819–1829.
   Google Scholar
• Bostanabad SZ, Velayati AA, Masjedi MR, Titov LP, Taghikhani M, Khazaei HA, et al. katG mutation of isoniazid-resistant isolated from tuberculosis patients. Tanaffos. 2006;5:31–36.
   Google Scholar
• Nguyen QH, Contamin L, Tran Thi TH, Nguyenet VH, Nguyen TNL, Nguyen TS, et al. Molecular analysis of pyrazinamide resistance in Mycobacterium tuberculosis in Vietnam highlights the high rate of pyrazinamide resistance-associated mutations in clinical isolates. Emerg Microbes Infect. 2017;6:e86.
   PubMed Web of Science ®Google Scholar
• Heifets L, Sanchez T. New agar medium for testing susceptibility of Mycobacterium tuberculosis to pyrazinamide. J Clin Microbiol. 2000;38:1498–1501.
   PubMed Web of Science ®Google Scholar
• Werngren J, Alm E, Mansjö M. Non-pncA gene-mutated but pyrazinamide-resistant mycobacterium tuberculosis: Why is that? J Clin Microbiol. 2017;55:1920–1927.
   PubMed Web of Science ®Google Scholar